David Pauling serves as Executive at SUTRO BIOPHARMA, INC., where they oversee executive responsibilities. Since joining the company, David Pauling has executed 1 insider transactions totaling $10.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 15, 2025 involved purchasing 12,504 shares valued at $10.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Oct 15, 2025 | STRO | $10.0K | Purchase | 12,504 | $0.80 | Discretionary |
David Pauling currently holds 71,737 shares of SUTRO BIOPHARMA, INC. (STRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Pauling has been a net buyer of STRO stock. They have purchased $10.0K and sold $0 worth of shares.
David Pauling's most recent insider trade was on Oct 15, 2025, when they purchased 12,504 shares at $0.80 per share.
Get notified when new Form 4 filings are submitted